Inventor
Keith C. Murdock
Inventor
Pearl River, NY, US
Overview
Patents· 39 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
C07CAcyclic or carbocyclic compounds3%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%
C02FTreatment of water, waste water, sewage, or sludge1%
C07HSugars1%
C07KPeptides1%
PatentTitleYear
5,212,291'Anthracycline derivatives as solubilized pro-drugs'19935,116,827'Quinolinecarboxylic acid derivatives as solubilized pro-drugs'19925,077,283'Solubilized imidazole pro-drugs'19915,077,282'Solubilized pro-drugs'19915,070,082'Solubilized pro-drugs'19914,900,838'Acylation products of bis(2-imidazolin-2-ylhydrazones) of 9,10-anthracenedicarboxaldehyde'19904,888,137'Novel 1,4-bis(substituted-amino(-5,8-dihydroxyanthraquinones and leuco bases thereof'19894,820,738'1,4-bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof'19894,732,970'Antitumor amino acid and peptide derivatives of 1,4-bis(aminoalkyl and hydroxy-aminoalkyl)amino)-5,8-dihydroxyanthraquinones'19884,715,993'Process for preparing certain 1,4-di[.omega.-(2-hydroxyethylamino)alkylamino]anthraquinone free bases'19874,696,935'Method of treating transplanted tumors and modulating the immune response'19874,614,618'1,4-bis(substituted-amino)-5,8-dihydroxy anthraquinones and leuco bases thereof'19864,540,583'Method of treating tumors in warm-blooded animals'19854,540,519'1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof'19854,540,788'Schiff bases of [(aminoalkyl or substituted aminoalkyl)amino]-9,10-anthracenediones'19854,526,788'Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones'19854,526,989'1,4-Bis (substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof'19854,515,954'Metal chelates of anthracene-9,10-bis-carbonylhydrazones'19854,456,552'1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof'19844,430,501'1,4-Bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof'19844,428,882'1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones'19844,418,078'Method of treating tumors in warm-blooded animals'19834,410,524'Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof'19834,389,399'Thiocarbamoyl heterocycle-anthraquinone derivatives'19834,375,469'Oxaza heterocycle-anthraquinones, pharmaceutical compositions thereof and method of use thereof'19834,333,875'5,8-Dihydroxy-1,4-bis(guanidinylamino)anthraquinones'19824,314,061'Certain 3,6-bis-(heteroaminoalkoxy) acridines'19824,296,030'Metal chelates of 1,4-bis(substituted-amino-5,8-dihydroxy-anthraquinones'19814,278,689'1,4-Bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof'19814,278,605'Heteroalkylenebisanthraquinones'19814,275,009'1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones'19814,275,010'5,8-Dihydroxy-1,4-bis(guanidinylamino)anthraquinones'19814,258,181'Substituted 9,10-anthracenebishydrazones'19814,226,869'Method of stimulating the immune response with halogenated 10-(.omega.-dialkylaminopolymethyleneamino)-2-methoxypyrido[3,2-b]quinol ines'19804,197,249'1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof'19804,141,992'Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic agents'19794,138,415'1,4-Bis(aminoalkylamino)-anthraquinones and leuco derivatives thereof'19794,131,676'2,6-Bis(1-morpholinoalkylideneamino)anthraquinones as anti-amebic agents'19784,118,498'2,6-Bis(1-piperidinoalkylideneamino)anthraquinones and method of treating cecal and hepatic amebic infections therewith'1978Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1978–1993Patents assigned to AMERICAN CYANAMID CO (38)· patent assignee history
1978–1993Based in Pearl River, NY, US· patent location history
1978Based in Pear River, NY, US· patent location history
1982Patents assigned to DAMIANI MARTIN R (1)· patent assignee history
1982Patents assigned to DURR FREDERICK E (1)· patent assignee history
1982Patents assigned to MURDOCK KEITH C (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMERICAN CYANAMID CO | 38 | 1978–1993 |
| DAMIANI MARTIN R | 1 | 1982 |
| DURR FREDERICK E | 1 | 1982 |
| MURDOCK KEITH Cself | 1 | 1982 |
Locations
| Location | Patents | Span |
|---|---|---|
| Pearl River, New York, US | 38 | 1978–1993 |
| Pear River, New York, US | 1 | 1978 |